Literature DB >> 19941066

Changes in extracellular kynurenic acid concentrations in rat prefrontal cortex after D-kynurenine infusion: an in vivo microdialysis study.

Tadahiro Ogaya1, Ziyu Song, Kana Ishii, Takeshi Fukushima.   

Abstract

Using a microdialysis technique, we continuously infused D-kynurenine (KYN) (0, 50, and 100 microM) into the prefrontal cortices (PFCs) of male Sprague-Dawley rats. We then used column-switching high-performance liquid chromatography to assess the alterations in the concentration of kynurenic acid (KYNA)-an antagonist of N-methyl-D-aspartate and alpha7 nicotinic acetylcholine receptors-in the extracellular fluid in the PFC. Local infusion of D-KYN into the PFC remarkably increased the extracellular KYNA concentration, indicating that D-KYN is metabolized to KYNA in the PFC. The D-KYN-induced increase in KYNA levels was significantly attenuated by the co-administration of 3-methylpyrazole-5-carboxylic acid (AS057278)-a specific inhibitor of D-amino acid oxidase (DAAO). These results suggest that DAAO may be involved in the production of KYNA from D-KYN in the PFC in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19941066     DOI: 10.1007/s11064-009-0099-1

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  38 in total

1.  Metabolism of D-tryptophan in the normal human subject.

Authors:  R R LANGNER; C P BERG
Journal:  J Biol Chem       Date:  1955-06       Impact factor: 5.157

2.  The metabolism of d- and l-tryptophan and d- and l-kynurenine by liver and kidney preparations.

Authors:  M MASON; C P BERG
Journal:  J Biol Chem       Date:  1952-04       Impact factor: 5.157

Review 3.  Quantitative aspects of tryptophan metabolism in humans and other species: a review.

Authors:  J E Leklem
Journal:  Am J Clin Nutr       Date:  1971-06       Impact factor: 7.045

4.  The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications.

Authors:  C Hilmas; E F Pereira; M Alkondon; A Rassoulpour; R Schwarcz; E X Albuquerque
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

5.  Increased cortical kynurenate content in schizophrenia.

Authors:  R Schwarcz; A Rassoulpour; H Q Wu; D Medoff; C A Tamminga; R C Roberts
Journal:  Biol Psychiatry       Date:  2001-10-01       Impact factor: 13.382

6.  Production of D-kynurenine and other metabolites from D-tryptophan by the intact rabbit and by rabbit tissue.

Authors:  H H Loh; C P Berg
Journal:  J Nutr       Date:  1971-04       Impact factor: 4.798

7.  D-amino acid oxidase (DAO) genotype and mood symptomatology in schizophrenia.

Authors:  Aiden Corvin; Gary Donohoe; Kevin McGhee; Kevin Murphy; Niamh Kenny; Siobhan Schwaiger; Jeanne Marie Nangle; Derek Morris; Michael Gill
Journal:  Neurosci Lett       Date:  2007-09-08       Impact factor: 3.046

8.  Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia.

Authors:  Caroline Madeira; Maria Eliza Freitas; Charles Vargas-Lopes; Herman Wolosker; Rogério Panizzutti
Journal:  Schizophr Res       Date:  2008-04-02       Impact factor: 4.939

9.  Crystal structure of human kynurenine aminotransferase I.

Authors:  Franca Rossi; Qian Han; Junsuo Li; Jianyong Li; Menico Rizzi
Journal:  J Biol Chem       Date:  2004-09-10       Impact factor: 5.157

10.  d-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia.

Authors:  Louise Verrall; Mary Walker; Nancy Rawlings; Isabel Benzel; James N C Kew; Paul J Harrison; Philip W J Burnet
Journal:  Eur J Neurosci       Date:  2007-09       Impact factor: 3.386

View more
  7 in total

1.  D-Amino-Acid Oxidase Inhibition Increases D-Serine Plasma Levels in Mouse But not in Monkey or Dog.

Authors:  Camilo Rojas; Jesse Alt; Nancy A Ator; Ajit G Thomas; Ying Wu; Niyada Hin; Krystyna Wozniak; Dana Ferraris; Rana Rais; Takashi Tsukamoto; Barbara S Slusher
Journal:  Neuropsychopharmacology       Date:  2015-10-16       Impact factor: 7.853

2.  Adolescent stress leads to glutamatergic disturbance through dopaminergic abnormalities in the prefrontal cortex of genetically vulnerable mice.

Authors:  Yurie Matsumoto; Minae Niwa; Akihiro Mouri; Yukihiro Noda; Takeshi Fukushima; Norio Ozaki; Toshitaka Nabeshima
Journal:  Psychopharmacology (Berl)       Date:  2017-07-29       Impact factor: 4.530

3.  Enzymatic transamination of D-kynurenine generates kynurenic acid in rat and human brain.

Authors:  Veronica Pérez-de la Cruz; Laura Amori; Korrapati V Sathyasaikumar; Xiao-Dan Wang; Francesca M Notarangelo; Hui-Qiu Wu; Robert Schwarcz
Journal:  J Neurochem       Date:  2012-02-02       Impact factor: 5.372

4.  Kynurenic acid and 3-hydroxykynurenine production from D-kynurenine in mice.

Authors:  Xiao-Dan Wang; Francesca M Notarangelo; Ji-Zuo Wang; Robert Schwarcz
Journal:  Brain Res       Date:  2012-03-17       Impact factor: 3.252

5.  Role of d-amino acid oxidase in the production of kynurenine pathway metabolites from d-tryptophan in mice.

Authors:  Francesca M Notarangelo; Xiao-Dan Wang; Kyle J Horning; Robert Schwarcz
Journal:  J Neurochem       Date:  2016-01-13       Impact factor: 5.372

6.  Alteration in the plasma concentration of a DAAO inhibitor, 3-methylpyrazole-5-carboxylic acid, in the ketamine-treated rats and the influence on the pharmacokinetics of plasma D-tryptophan.

Authors:  Naomi Haruta; Hideaki Iizuka; Kana Ishii; Shunsuke Yoshihara; Hideaki Ichiba; Takeshi Fukushima
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

7.  Paroxetine engenders analgesic effects through inhibition of p38 phosphorylation in a rat migraine model.

Authors:  Chuanming Wang; Wei Bi; Yanran Liang; Xiuna Jing; Songhua Xiao; Yannan Fang; Qiaoyun Shi; Enxiang Tao
Journal:  Neural Regen Res       Date:  2012-05-05       Impact factor: 5.135

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.